This inventor holds 2 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent. Top assignees: Children's Medical Center Corporation, Leland Stanford Junior University. Active years: 2006-2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2006-2007
Title: The Innovations of Ryan Watts
Introduction
Ryan Watts is an accomplished inventor based in Stanford, CA. He has made significant contributions to the field of neuroscience, particularly in the area of axon degeneration. With a total of 2 patents, his work has the potential to impact the treatment of degenerative neuropathies.
Latest Patents
One of Ryan's latest patents focuses on reducing axon degeneration with proteasome inhibitors. This innovative approach aims to reduce the degeneration of an axon predetermined to be subject to degenerative neuropathy in a patient. The method involves contacting the axon in situ with an effective amount of a ubiquitin-proteasome system (UPS) inhibitor, which is sufficient to reduce degeneration. The effectiveness of this treatment is then detected by observing a resultant reduction in the degeneration of the axon in situ.
Career Highlights
Throughout his career, Ryan has worked with notable organizations such as Children's Medical Center Corporation and Leland Stanford Junior University. His experience in these institutions has allowed him to develop and refine his innovative ideas in the field of neuroscience.
Collaborations
Ryan has collaborated with esteemed colleagues, including Zhigang He and Qiwei Zhai. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Ryan Watts is a notable inventor whose work in reducing axon degeneration has the potential to transform treatment options for patients with degenerative neuropathies. His contributions to the field are significant and continue to inspire further research and innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile